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OBJECTIVE—The development of obesity-related metabolic disorders varies with ethnicity.
We examined whether ethnicity modiﬁes the relationship between BMI and three metabolic
pathways (insulin resistance, inﬂammation, and adiponectin) that are involved in the pathogen-
esis of diabetes and cardiovascular disease (CVD).
RESEARCH DESIGN AND METHODS—We analyzed data from 4,804 Chinese, Malay,
andAsian-IndianresidentsofSingaporewithcompletedataoninsulinresistance(IR),C-reactive
protein (CRP), and total adiponectin levels. Linear regression models with an interaction term
ethnicity*BMIwereusedtoevaluatewhetherethnicitymodiﬁestheassociationbetweenBMIand
IR, CRP, and adiponectin.
RESULTS—In both uni- and multivariate analyses, BMI was directly associated with IR and
CRP and inversely with adiponectin across all ethnic groups. When compared with Chinese and
Malays, Asian-Indians had higher IR and CRP and lower adiponectin levels. The associations
between BMI and its metabolic pathways were signiﬁcantly stronger in Chinese than in other
ethnic groups. The increase in IR and CRP and the decrease in adiponectin for each unit increase
inBMIweregreaterinChinesethaninotherethnicgroups.Theﬁndingsweresimilarwhenwaist
circumference was used in the analyses instead of BMI.
CONCLUSIONS—TheimpactofBMIonIR,CRP,andadiponectinappearsgreaterinChinese
as compared with other major Asian ethnic groups. This may partly explain the rapid increase in
the prevalence of diabetes and CVD in Chinese populations and highlights the importance of
weight management in Asian ethnic groups despite the apparently low levels of obesity.
Diabetes Care 34:1120–1126, 2011
T
ype 2 diabetes and cardiovascular
disease (CVD) are important causes
of mortality and morbidity in devel-
oping countries. Increasing levels of obe-
sity are an important contributor to the
increasing rates of type 2 diabetes and
CVD (1). Insulin resistance (IR) repre-
sents a fundamental defect in type 2 di-
abetes and precedes the disease for many
years (2). However, not all obese people
are insulin resistant. Studies have shown
that obesity only explains about 22% var-
iability in IR, and individuals can have
very different levels of IR for the same
level of obesity (3).
Individuals from different ethnic
groups show different levels of IR. In par-
ticular,ithasbeenobservedthatindividuals
of Asian ethnicity experience high rates of
type 2 diabetes and CVD despite much
lower levels of obesity compared with
their Caucasian counterparts. This has
led the World Health Organization to
recommend that a BMI above 23 kg/m
2
should be a trigger point for public health
action in Asian populations (4). Several
studies have shown that, when compared
with Caucasians, South Asians (Asian-
Indians) have higher levels of IR for the
same level of BMI (5). In our own studies,
we have shown that within Asia, different
ethnic groups exhibit different levels
of IR, even after adjusting for the level of
obesity (6).
The pathophysiological impact of
obesity extends beyond IR. It has become
evidentthatobesityisastateofsubclinical
systemic inﬂammation. Using C-reactive
protein (CRP) as a measure of inﬂamma-
tion,studieshaveshownthathigherBMIis
associated with higher CRP levels (7). In
turn, atherosclerosis is also an inﬂamma-
toryprocess.ElevatedCRPlevelspredicted
higherfuturecardiovasculareventsinindi-
viduals with and without CVD (8).
Finally, it is now established that
adipocytes play an active role in energy
homeostasis by secreting various impor-
tant adipokines that regulate metabolism.
One of these adipokines, adiponectin, is
a potent regulator of glucose and lipid
metabolism and possesses antiathero-
genic and anti-inﬂammatory properties.
In humans, adiponectin levels decrease
with increasing levels of obesity, and
several prospective studies have demon-
strated that low adiponectin levels are
associated with increased risk of CVD
andtype2diabetes(9).Adiponectinlevels
also differ between ethnic groups and are
lower in Asian-Indians compared with
Europeans (5).
What is unclear is whether the effects
of ethnicity are direct, and independent
of obesity, or whether ethnicity alters the
relationship between obesity and IR. The
distinction is important because the lat-
t e rw o u l ds u g g e s tt h a te f f o r t st op r e -
vent or treat obesity may be particularly
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ORIGINAL ARTICLEimportant and efﬁcacious in reducing the
burden of type 2 diabetes in some pop-
ulations. This is particularly relevant in
Asia,wherethemostrapidincreaseintype
2 diabetes and CVD is being experienced
(10). To the best of our knowledge, only
one study has examined the association of
ethnicity ontherelationship betweenobe-
sity and CRP (11), and this has not been
examined in Asians. In another study, the
inverse relationship between obesity and
adiponectin appeared to be attenuated in
Asian-Indianscomparedwithotherethnic
groups (5).
We therefore compared the associa-
tion between obesity (measured by BMI)
and 1)I R ;2)C R P ;a n d3) adiponectin
in Chinese, Malays, and Asian-Indians
living in Singapore. We also tested the
hypothesis that ethnicity might modify
the relationship between obesity and the
three pathogenic pathways in an Asian
population.
RESEARCH DESIGN AND
METHODS
Study design and population
Essentially,10,445participantsfromfour
previously conducted population-based
cross-sectional surveys carried out in
Singapore (1982–1998) were invited to
participate in a repeat examination from
2004 to 2007. The four studies included
theThyroidandHeartStudy1982–1984,
the National Health Survey 1992, the
National University of Singapore Heart
Study 1993–1995, and the National
Health Survey 1998. Detailed methodol-
ogies for these studies have been previ-
ously described (12). Brieﬂy, all studies
were a random sample of individuals
from the Singapore population, with
oversampling of the minority ethnic
groups (Malays and Asian-Indians). The
recruitment and exclusion process is
summarized in Supplementary Fig. A1.
There were 517 participants who were
deceased at the time of follow-up, 6 had
emigrated, and 85 had errors in the iden-
tity card numbers. Remaining participants
were contacted to obtain an appointment
for investigators to administer a question-
naire at the participant’sh o m e s .T h r e e
home visits were made on three differ-
ent occasions including 1 weekend and
weekday before a participant was deemed
noncontactable. After this procedure,
2,673 participants were noncontactable.
Of those participants who were contact-
able, 30 participants (0.3%) refused to
participate. All participants were invited
to attend a health examination for addi-
tional tests and collection of biological
specimens shortly after the home visit. A
total of 8,411 participants completed the
questionnaire, of which 5,815 (69.1% of
thosewhocompletedthequestionnaireor
49.6% of all eligible participants) also at-
tendedthehealthexamination.Wealsoex-
cluded participants who reported their
ethnic group asotherthanChinese, Malay,
orAsian-Indian(n = 13) and participants
with missing laboratory information (n =
380). Thus our ﬁnal analyses included
4,804 participants.
Ethics approval was obtained from
twoInstitutionalReviewBoards(National
University of Singapore and Singapore
General Hospital). Informed consent was
obtained before conducting the study.
Data collection
Demographic data were collected using
interviewer-administered questionnaires.
Information on socio-demographic his-
tory, lifestyle (smoking history), medical
history, and medication use was recorded.
The methodologies for the measurement
of height, weight, and blood pressure
(BP) have been previously described
(12). Following a 10-h overnight fast, ve-
nous blood was drawn and collected
in plain and ﬂuoride oxalate tubes and
stored at 4°C for a maximum of 4 h before
processing.
All biochemical analyses were carried
out at the National University Hospital
ReferralLaboratory,whichwasaccredited
by the College of American Pathologists.
Plasma glucose was assayed using en-
zymatic methods (ADVIA 2400; Bayer
Diagnostics). Serum total cholesterol, tri-
glycerides, and HDL cholesterol (HDL-C)
were measured using an automated auto-
analyzer (ADVIA 2400; Bayer Diagnos-
tics). LDL cholesterol (LDL-C) levels
were calculated using the Friedewald
formula. Serum CRP was measured using
the hs-CRP immunoturbidimetric assay
implemented on a Roche Integra 400
(intra- and interassay CV of 0.6–1.3 and
2.3–3.1%, respectively). The detection
limit of this assay is 0.07 mg/L, and the
CV is 2.9% at 6.3 mg/L and 3.9% at 108
mg/L mean value. Insulin was assayed by
microparticleenzymeimmunoassayusing
the Bayer ADVIA Centaur chemilumines-
cent assay (intra- and interassay CV of 4.0
and 4.5%, respectively). IR was assessed
by the homeostasis model assessment.
Fasting serum adiponectin were deter-
mined using a sandwich enzyme-linked
immunosorbent assay using an antibody
speciﬁc for all multimeric forms of human
adiponectin (Daiichi Pure Chemicals,
Japan) with intra- and interassay CV of
3.3 and ,1.5%, respectively.
Statistical methods
Allvaluesweregivenasmeans6SDunless
stated otherwise. The statistical analyses
werecarriedoutusingtheSPSSsoftware
version 17 (SPSS, Chicago, IL). All statis-
tical tests were two-sided, and a P value ,
0.05 was considered signiﬁcant.
I R ,C R P ,a n da d i p o n e c t i nw e r el o g -
transformed to improve normality. Anal-
yses of the CRP levels were limited to a
maximum of 10 mg/L (n = 212 for CRP
.10 mg/L), as suggested by the Centers
for Disease Control and the American
Heart Association, because extremely ele-
vated values were of indeterminate signif-
icance without accompanying clinical
correlation (13). BMI was computed us-
ing weight in kilograms divided by the
square of height in meters. To compare
continuous variables between ethnic
groups and/or sex, the Student t test was
used for two-group comparisons of con-
tinuous variables, whereas ANOVA was
used for comparisons in more than two
groups, with Bonferroni corrections ap-
plied for pairwise comparisons. The x
2
tests were used to compare proportions.
Pearson correlation analysis was used to
assess relationships between ln-IR, ln-
CRP, and ln-adiponectin with other con-
tinuous variables.
We then performed ANCOVA to
examine the effect of ethnicity on the
relationship between 1)B M Ia n dI R ,
2)B M Ia n dC R P ,a n d3)B M Ia n da d i p o -
nectin.Analyseswereperformedwithand
without adjustment for age, smoking sta-
tus, history of CVD (myocardial infarction,
stroke, or transient ischemic attack), his-
tory of type 2 diabetes, use of aspirin, or a
statin. For these analyses, ln-IR, ln-CRP,
andln-adiponectinwereenteredasdepen-
dent variables in separate analyses, with
ethnicity (three levels) and BMI as co-
variates. The cross-product interaction
term, ethnicity*BMI, was included as an
independent variabletotestforethnicdif-
ferences in the relationship between BMI
and IR, CRP, or adiponectin. We then
calculated the predicted values for ln-IR,
ln-CRP, and ln-adiponectin based on
the regression model. The predicted val-
ues were plotted against BMI for each eth-
nic group. All analyses were stratiﬁed by
sex because of previous data that showed
that the associations between BMI and
CRP and between BMI and adiponectin
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Khoo and Associateswere modiﬁed by sex (14), and this sex
interaction was also observed in the cur-
rent study (see Supplementary Fig. A2).
RESULTS—Our study population in-
cluded 4,804 participants, comprising
65.3% Chinese, 18.1% Malays, and
16.6% Asian-Indians, with a slight pre-
dominance ofwomen (55.1%).The mean
age and BMI were 49.4 6 12.2 years and
24.0 6 4.4 kg/m
2, respectively. Baseline
demographic, clinical, and biochemical
characteristics are summarized in Table 1.
Asian-Indians had the least favorable car-
diovascular risk proﬁles. Asian-Indians
were signiﬁcantly older and had higher
fasting glucose, IR, and CRP but lower
HDL-C and adiponectin levels (all P values
, 0.01,withBonferronicorrection).How-
ever, Malays had signiﬁcantly higher sys-
tolic BP and LDL-C levels compared with
Chinese and Asian-Indians.
Table 2 shows the correlation be-
tween measuresofobesity (BMIand waist
circumference); metabolic proﬁles; and
IR, CRP, and adiponectin for males and
femalesinourstudypopulation.Afterad-
justment for age and ethnicity, BMI was
positivelycorrelatedwithIRand CRPand
inversely correlated with adiponectin.
Both IR and CRP were signiﬁcantly
correlated with systolic BP, diastolic BP,
and triglycerides and inversely with
HDL-C(allPvalues,0.001).Onthecon-
trary, adiponectin has a signiﬁcant inverse
correlation with diastolic BP, fasting insu-
lin, fasting glucose, and triglycerides but
positive correlation with HDL-C (all
P values , 0.001).
Effects of ethnicity on the relationship
betweenBMIandIR,CRP,andadiponectin
are shown in Fig. 1 and in Supplementary
Table A1. The association between BMI
and IR differed signiﬁcantly between eth-
nic groups. Although increasing levels of
BMI were associated with increased IR
and CRP and reduced adiponectin in all
three ethnic groups, each unit increase in
BMI was associated with a larger increase
in IR and CRP, and a larger decline in adi-
ponectininChinesecomparedwithMalays
and Asian Indians. This interaction was
particularly pronounced in women (P in-
teraction, 0.001forIR,CRP,andadipo-
nectin). In men, interactions were in the
samedirectionasforwomen,butreached
statistical signiﬁcance only for adiponec-
tin. Further adjustment for age, smoking
status, history of CVD, type 2 diabetes,
use of aspirin, or statins did not substan-
tially alter the effect of ethnicity on the re-
lationship between BMI and IR, CRP, and
adiponectin(datanotshown).Inaddition,
whenweusedwaistcircumferenceinstead
ofBMI intheanalyses,the interactionsbe-
tween waist circumference and ethnicity
were essentially the same as for BMI and
ethnicity (see Supplementary Table A2
and Supplementary Fig. A3).
CONCLUSIONS—Based on our anal-
ysis of data from a large cross-sectional
study, which included three major Asian
ethnicgroups(Chinese,Malays,andAsian-
Indians) residing in Singapore, ethnic dif-
ferences were observed for IR, CRP, and
adiponectin. Some of these differences
were independent of BMI, with greater IR,
higher CRP, and lower adiponectin ob-
served in Malays and Asian-Indians as
compared with Chinese. However, the
relationship between BMI and these
parameters also differed between ethnic
groups such that increases in BMI were
associatedwithgreaterchangesinallthree
parameters (IR, CRP, and adiponectin) in
Chinese as compared with Malays and
Asian-Indians.
Weconﬁrmed thatAsian-Indiansand
Malays have more unfavorable risk pro-
ﬁles for type 2 diabetes and CVD when
compared with Chinese. This is consistent
with data from other studies that have
Table 1—Demographic characteristics of study participants by sex and ethnic group
Men Women *PANOVA
men
†PANOVA
women Chinese Malays Asian-Indians Chinese Malays Asian-Indians
Age (years) 50.4 6 12.3 50.3 6 11.5 52.9 6 11.7 49.1 6 11.6 49.5 6 11.6 51.5 6 10.6 0.001 0.001
BMI (kg/m
2) 23.5 6 3.4 25.3 6 4.0 24.8 6 3.7 22.4 6 3.8 26.9 6 4.9 26.6 6 4.6 ,0.001 ,0.001
Waist circumference (cm) 87.4 6 9.3 90.3 6 10.2 93.2 6 10.8 77.2 6 9.4 86.0 6 11.5 88.3 6 10.8 ,0.001 ,0.001
BP (mmHg)
Systolic 134.3 6 18.8 135.7 6 18.6 133.3 6 17.9 127.5 6 21.5 139.1 6 22.9 134.6 6 24.4 0.173 ,0.001
Diastolic 81.3 6 10.5 81.89 6 9.8 81.4 6 10.0 73.44 6 9.7 77.39 6 10.8 76.12 6 10.3 0.760 ,0.001
Total cholesterol (mmol/L) 5.15 6 0.9 5.45 6 1.00 5.12 6 0.92 5.22 6 0.94 5.50 6 1.02 5.22 6 0.93 ,0.001 ,0.001
Triglycerides (mmol/L) 1.50 6 0.95 1.68 6 0.91 1.55 6 0.81 1.14 6 0.71 1.40 6 1.45 1.35 6 0.66 ,0.001 ,0.001
HDL-C (mmol/L) 1.32 6 0.29 1.23 6 0.27 1.15 6 0.26 1.61 6 0.36 1.48 6 0.31 1.32 6 0.29 ,0.001 ,0.001
LDL-C (mmol/L) 3.14 6 0.81 3.45 6 0.93 3.26 6 0.84 3.09 6 0.83 3.38 6 0.99 3.29 6 0.77 ,0.001 ,0.001
Fasting glucose (mmol/L) 5.15 6 1.23 5.52 6 2.26 5.78 6 2.10 4.85 6 1.11 5.38 6 2.00 5.65 6 2.20 ,0.001 ,0.001
Fasting insulin (mU/L) 7.44 6 6.51 8.73 6 7.57 11.45 6 11.13 7.01 6 5.04 9.23 6 5.60 12.00 6 8.82 ,0.001 ,0.001
HOMA-IR 1.76 6 1.72 2.23 6 2.54 3.02 6 3.26 1.58 6 1.43 2.28 6 1.84 3.18 6 3.18 ,0.001 ,0.001
CRP (mg/L) 2.11 6 5.89 2.82 6 4.23 3.25 6 7.10 2.02 6 4.33 3.64 6 4.89 5.71 6 8.36 0.001 ,0.001
Total adiponectin (mg/mL) 3.10 6 1.79 2.97 6 1.80 2.97 6 1.75 4.60 6 2.50 4.28 6 2.52 3.83 6 1.95 0.268 ,0.001
CVD (%) 5.1 5.1 13.4 1.4 2.0 3.9 ,0.001 0.003
Diabetes (%) 7.3 10.7 19.8 5.0 12.4 18.6 ,0.001 ,0.001
Statin use (%) 10.4 10.5 18.0 6.8 9.5 11.5 ,0.001 0.003
Aspirin use (%) 5.3 5.1 13.7 1.4 2.0 3.9 ,0.001 0.003
Current smokers (%) 19.5 34 21.8 2.6 2.7 0.7 ,0.001 0.001
Data are expressed as mean 6 SD or as % (proportion to the group). The x
2 test was used for categorical variables to compare differences between the ethnic groups.
Formen,n= 1,390Chinese,428 Malays,and 388 Asian-Indians.For women,n= 1,745Chinese,444 Malays,and 409 Asian-Indians.HOMA-IR,homeostasis model
assessment-IR. CVD was deﬁned as history of coronary heart disease, stroke, or transient ischemic attack. Diabetes was deﬁned as history of diabetes with or without
treatment. *P value for comparison between the ethnic groups in men; †P value for comparison between the ethnic groups in women.
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Effects of BMI on metabolic pathways in Asiansshown that Malays and Asian-Indians
exhibit higher rates of these disorders
t h a nC h i n e s e( 1 5 ) .W eh a v ep r e v i o u s l y
shown that IR was greater in Asian-
Indians when compared with Chinese or
Malays across the range of glucose toler-
ance, and this was associated with more
unfavorable cardiovascular risk proﬁles
(16). Other studies have also shown
greater IR in Asian-Indians (5). This study
has now extended these ﬁndings to in-
clude CRP and adiponectin levels. We
showedthatAsian-Indianshavethehighest
CRP levels, followed by Malays and
Chinese. Several previous studies have
shown that CRP levels differ between
populations (17). In most Asian popula-
tions,CRPlevelsarelowerthaninWestern
populations (18). It is of some interest
that in the Singapore population, which
has a rate of mortality from CVD similar
to or higher than that in many developed
countries, the CRP levels are similar, if
not higher, than those in the U.S. (19).
This suggests that low CRP levels are not
intrinsic to any ethnic group but more
likely reﬂect reduced exposure to envi-
ronmental factors that would raise CRP.
Total adiponectin levels were the lowest
in Asian-Indians, a ﬁnding that is consis-
tent with the greater degree of IR previ-
o u s l yr e p o r t e di nt h i se t h n i cg r o u p( 2 0 ) .
In addition, we also observed that
ethnicity modiﬁes the relationship be-
tween BMI and IR, CRP, and adiponectin
inamannerthatishighlyconsistentacross
all three parameters. To our knowledge,
this has only been examined in two pre-
vious studies. In the National Health and
NutritionExaminationSurvey(NHANES)
study, it was shown that that the relation-
ship between BMI and CRP did not dif-
fer between white Americans, African
Americans, and Hispanic Americans
(11). However, this study did not include
individuals of Asian ethnicity. One previ-
ous study by Mente et al. (5) examined the
association between obesity and adiponec-
tin or IR and included signiﬁcant numbers
of Asians. This study found that Chinese
had similar levels of IR to Europeans,
whereas Asian-Indians had greater IR. In
addition, they also found that the associa-
tion between BMI and adiponectin was
weaker in Asian-Indians than in any of
theother ethnicgroupsstudied.Our study
corroborates these ﬁndings for the differ-
ence between Asian-Indians and Chinese
and extends them to include IR and CRP,
which were not reported in the study by
Mente et al. (5). Furthermore, we found
that Malays, similar to Asian-Indians, also
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Khoo and AssociatesFigure 1—Age-adjusted ﬁtted regression plots showing relationships between BMI and IR, CRP, and adiponectin in Chinese (○), Malays (△), and
Asian-Indians(□),stratiﬁedbysex.A:RelationshipofIRtoBMIinmen(Pinteraction=0.282).B:RelationshipofIRtoBMIinwomen(Pinteraction,
0.001).C:RelationshipofCRPtoBMIinmen(Pinteraction=0.304).D:RelationshipofCRPtoBMIinwomen(Pinteraction,0.001).E:Relationshipof
adiponectin to BMI in men (P interaction , 0.001). F: Relationship of adiponectin to BMI in women (P interaction , 0.001).
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Effects of BMI on metabolic pathways in Asiansexhibited a weaker association between
BMIandthesemeasures.Thisisimportant
because most studies in Asia have focused
on Japanese, Chinese, and Asian-Indians.
Asia also comprises a large number of
islands (such as Indonesia, East Timor,
and Philippines), which have been jointly
referred to as “Other Asian Islands.” The
populations of these islands are ethnically
distinct from those of Chinese, Japanese,
and Asian-Indians and can be expected to
experienceagreaterincreaseintheburden
fromCVDthaneitherIndiaorChina(21).
Malays, and other related ethnic groups,
represent 300–400 million people in-
habiting these Other Asian Islands. Data
from Singapore suggest that this ethnic
group is at high risk of diabetes and
CVD and represents a large understudied
population.
We considered several possible ex-
planations as to why increasing levels
of BMI were associated with greater in-
creases in IR and CRP and greater decline
in adiponectin in Chinese. First, it is well
recognized that despite a lower BMI,
Asian-Indians have a greater degree of
adiposity than Caucasians (4). Using a
four-compartment model, Deurenberg
et al. (22) have shown that for the same
age, sex, and BMI, Asian-Indians had the
highest body fat percentage followed by
Malays and Chinese. However, the rela-
tionship between BMI and adiposity was
similar between ethnic groups with no in-
teraction between ethnicity and BMI. As
such, we believe that ethnic differences in
the relationship between BMI and adipos-
ity per se do not account for the observed
interactions. Instead, the interactions
might represent ethnic-speciﬁc sensitivity
to the effects of increasing adiposity. This
may relate to differences in fat distribu-
tion with increasing levels of adiposity,
particularly in the visceral compartment.
Lear et al. (23), in the Multicultural
Community Health Assessment Trial
(M-CHAT), compared the relation be-
tween abdominal adipose tissue and total
body fat between people living in Canada
of aboriginal, Chinese, and Asian-Indian
origin with people of European origin.
They showed that ethnicity has an effect
on fat distribution between the subcuta-
neous and visceral compartments with in-
creasing levels of adiposity. However, this
study did not directly compare Chinese
with Asian-Indians, making it difﬁcult
to determine whether this could explain
the differences between Chinese and
Asian-Indians observed in our study. To
explore this further, we also extended our
analyses to use waist circumference in-
stead of BMI because waist circumference
has been shown to be more strongly re-
lated to visceral adiposity than BMI. We
observed that the ethnic differences in re-
gard to the relationship between adiposity
and IR, CRP, and adiponectin were essen-
tially the same for waist circumference as
for BMI. Third, it has recently been sug-
gested that the total adipose tissue in an
individual might have an upper limit ca-
pacity for storing fat optimally. Once this
capacity is exceeded, any further nutrient
excess will result in metabolic perturba-
tions such as IR and inﬂammation (24).
We postulate that Chinese may have a
lowercapacityforfatstorageandanexcess
caloric intake may result in greater meta-
bolic perturbations. It is also tempting to
implicate genetic differences between the
ethnic groups. However, to date, we do
not have any evidence for speciﬁc genetic
differences that may contribute to ethnic
differences in metabolic responses to ex-
cess adiposity. Finally, we also considered
the possibility that differential patterns
of immigration between the ethnic
groups could have resulted in differential
exposure to important environmental in-
ﬂuences on inﬂammation and obesity.
Unfortunately,wedonothavedetailedin-
formation on immigration for our study
participants.Inourstudy,the participants
from the four population-based cross-
sectional surveys were all Singapore resi-
dentswhentheywereﬁrststudied.Because
thisfollow-upwascarriedout5to20years
after the initial studies, all participants
had resided in Singapore for at least 5 to
20 years before participating in this study
and have been exposed to the similar
urbanized environment. Nevertheless, we
cannot exclude the possibility that earlier
exposure to different environments (such
asduringchildhood)mayunderlie some
of the ethnic differences that we have
observed.
Our study has several strengths. This
study included three major ethnic groups
(Chinese,Malays,andAsian-Indians)that
represent the majority of ethnic groups
living in Asia, a region where the pre-
valence of type 2 diabetes and CVD is
expected to increase over the next several
decadesandthe highestpopulation inthe
world. The large number of participants
with data collected in a standardized man-
ner minimizes measurement error and
potential biases. There are also limitations
in our study. The cross-sectional nature
of the study does not allow us to infer
causality. In addition, stratiﬁed sampling
for the minority ethnic groups means that
the study population may not be fully
representative of the Singapore popula-
tion. However, we feel that the nonrep-
resentativeness of the study population
does not impair our ability to make these
biologicallyrelevantobservations.Wealso
accept that BMI and waist circumference
are imperfect measures of adiposity and
that more deﬁnitive measures of adipos-
ity, including an assessment of fat distri-
bution, would have provided a better
understandingofthe interactions observed.
Finally, our study does not provide a
mechanistic basis for the interactions
observed. Mechanistic studies to explore
these ethnic differences are important.
Nevertheless, we believe that this is an
important hypothesis generating study
and provides some insight as to the rapid
increase in the rates of type 2 diabetes in
Chinese populations (1).
In conclusion, the relationships be-
tween BMI and three pathogenic path-
ways (IR, CRP, and adiponectin) are
modiﬁed by ethnicity. The negative im-
pact of increasing BMI on IR, CRP, and
adiponectin levels is more pronounced in
Chinese than the other ethnic groups.
This may have contributed to the rapid
increase in the prevalence of type 2 di-
abetes observed in China, which has been
accompanied by increasing levels of over-
weight and obesity (1). These ﬁndings
suggest that, as a public health strategy,
weight reduction or prevention of weight
gain is particularly important in many
Asian countries despite the relatively
lowlevelsofobesity.Inaddition,studies
between ethnic groups may provide in-
sight as to the interindividual differ-
ences in susceptibility to obesity-related
diseases.
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